Correlation Between Pfizer and BPCEGP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and BPCEGP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BPCEGP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and BPCEGP 2045 19 OCT 27, you can compare the effects of market volatilities on Pfizer and BPCEGP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BPCEGP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BPCEGP.

Diversification Opportunities for Pfizer and BPCEGP

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and BPCEGP is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BPCEGP 2045 19 OCT 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BPCEGP 2045 19 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with BPCEGP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BPCEGP 2045 19 has no effect on the direction of Pfizer i.e., Pfizer and BPCEGP go up and down completely randomly.

Pair Corralation between Pfizer and BPCEGP

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.33 times more return on investment than BPCEGP. However, Pfizer Inc is 3.07 times less risky than BPCEGP. It trades about -0.23 of its potential returns per unit of risk. BPCEGP 2045 19 OCT 27 is currently generating about -0.71 per unit of risk. If you would invest  2,842  in Pfizer Inc on August 27, 2024 and sell it today you would lose (225.00) from holding Pfizer Inc or give up 7.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy9.52%
ValuesDaily Returns

Pfizer Inc  vs.  BPCEGP 2045 19 OCT 27

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
BPCEGP 2045 19 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BPCEGP 2045 19 OCT 27 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for BPCEGP 2045 19 OCT 27 investors.

Pfizer and BPCEGP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and BPCEGP

The main advantage of trading using opposite Pfizer and BPCEGP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BPCEGP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BPCEGP will offset losses from the drop in BPCEGP's long position.
The idea behind Pfizer Inc and BPCEGP 2045 19 OCT 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio